Ocuflox
Aspirin Linked to Blinding Eye Disease »
"Jan. 22, 2013 -- Regular aspirin users are more likely to develop the "wet" form of age-related macular degeneration compared to people who rarely or never take the drug, a new study shows.
Aspirin is one of the most widely used drugs in th"...
Ocuflox
INDICATIONS
OCUFLOX (ofloxacin ophthalmic) ® ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below:
| CONJUNCTIVITIS: | |
| Gram-positive bacteria: | Gram-negative bacteria: |
| Staphylococcus aureus | Enterobacter cloacae |
| Staphylococcus epidermidis | Haemophilus influenzae |
| Streptococcus pneumoniae | Proteus mirabilis |
| Pseudomonas aeruginosa | |
| CORNEAL ULCERS: | |
| Gram-positive bacteria: | Gram-negative bacteria: |
| Staphylococcus aureus | Pseudomonas aeruginosa |
| Staphylococcus epidermidis | Serratia marcescens* |
| Streptococcus pneumoniae | Anaerobic species: |
| Propionibacterium acnes | |
| *Efficacy for this organism was studied in fewer than 10 infections | |
DOSAGE AND ADMINISTRATION
The recommended dosage regimen for the treatment of bacterial conjunctivitis is:
| Days 1 and 2 | Instill one to two drops every two to four hours in the affected eye(s). |
| Days 3 through 7 | Instill one to two drops four times daily. |
| The recommended dosage regimen for the treatment of bacterial corneal ulcer is: | |
| Days 1 and 2 | Instill one to two drops into the affected eye every 30 minutes, while awake. Awaken at approximately four and six hours after retiring and instill one to two drops. |
| Days 3 through 7 to 9 | Instill one to two drops hourly, while awake. |
| Days 7 to 9 through treatment completion | Instill one to two drops, four times daily. |
HOW SUPPLIED
OCUFLOX® (ofloxacin ophthalmic solution) 0.3% is supplied sterile in opaque white LDPE plastic bottles and white dropper tips with beige high impact polystyrene (HIPS) caps as follows:
5mL in 10mL bottle - NDC 11980-779-05
Note: Store at 15-25°C (59-77°F)
Rev May 2005. Allergan, Inc. Irvine, CA 92612, U.S.A. Licensed from: Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan and Santen Pharmaceutical Co., Ltd., Osaka, Japan
Last reviewed on RxList: 5/6/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Ocuflox Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Daily
Get breaking medical news.
Updated & New
